Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,608 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma

NCT00124605

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00253578

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma

NCT00882063

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Jaslok Hospital & Research Centre Mumbai, Maharashtra, India

Shatabdi Superspeciality Hospital Nashik, Maharashtra, India

Rajiv Gandhi Cancer Institute And Research Centre Delhi, National Capital Territory of Delhi, India

Institute Rotary Cancer Hospital,All India Institute Of Medical Sciences(AIIMS) New Delhi, India

View Trial Details

Completed

4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis

NCT00003853

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

University of Pavia Pavia, Italy

View Trial Details

Completed

Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

NCT00513175

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +61 more
Locations: University of California San Francisco San Francisco, California, United States

View Trial Details

Completed

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

NCT00900406

Conditions: Adnexal Diseases, Blood Protein Disorders, Bone Marrow Diseases, +58 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

NCT00005622

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +56 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma

NCT00012350

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma

NCT00920855

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Pacific Oncololgy & Hematology Encinitas, California, United States

Capitol Hematology Oncology Roseville, California, United States

University Of California, San Diego San Diego, California, United States

James R. Berenson, M.D., Inc. West Hollywood, California, United States

View all 13 locations

View Trial Details

Completed

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

NCT00255749

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +64 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Multiple Myeloma

Multiple Myeloma trial results

Related conditions